Kyriacos Mitrophanous PhD
Head of Research
Dr Kyriacos Mitrophanous obtained his PhD from the University of London where he worked on chemokine receptors. He then moved to Oxford University where he was involved in a number of research areas, particularly Lentiviral vector development. He is a named inventor on several patents in the field.
James Miskin PhD
Head of Manufacturing and Product Release
Dr James Miskin obtained his PhD in 1995 from the University of Leeds where he worked on the molecular biology of a bacterium associated with acne. After completing his PhD he moved to The Institute for Animal Health, Pirbright Laboratory where he investigated viral-host interactions of African Swine Fever Virus. Since moving to Oxford BioMedica in December 2000, he worked in a number of research areas, in particular developing methods to investigate the safety profile of Lentiviral vectors. He is a named inventor on several patents in the field.
Richard Harrop D.Phil. BSc
Head of Clinical Analysis
Dr Richard Harrop obtained his D.Phil from York University in 1993 and then spent the next 6 years researching vaccine based approaches to tackle common viral and parasitic diseases. He joined Oxford BioMedica in 1999 and now heads the clinical immunology team. He is a named inventor on several patents and has published widely on Oxford BioMedica's key products.
Jill Martin
Vice President, Intellectual Property - US
Jill Martin joined Oxford BioMedica's US subsidiary in 2001 and has contributed to the management of our US patent estate as well as our in-licensing and LentiVector out-licensing activities. Jill is a registered Patent Agent and a member of the BIO IP Committee. Prior to joining BioMedica, she was a US Patent Examiner in the biotechnology group.
|
 |
Graham Price MBBS BSc
Chief Medical Officer
Dr Graham Price joined Oxford BioMedica in March 2010. He has 15 years experience in the pharmaceutical industry within clinical research, having previously held senior leadership positions in Medimmune, Takeda Global R&D and Servier. He has bachelor’s degrees in neuroscience and in Medicine and Surgery from Imperial College of Science Technology and Medicine, London. He is a member of the Faculty of Pharmaceutical Medicine and Consultant in Pharmaceutical Medicine from the Royal Colleges of Physicians of Edinburgh and London, and the Royal College of Surgeons of Glasgow. He has experience of successful management of people, global portfolio management, global product development, clinical program and alliance management. He has a background in a variety of therapeutic areas including hypertension, respiratory, heart failure, metabolic diseases, retinopathy, migraine, anticoagulation, inflammation, autoimmune and atherosclerosis.
Adam Love MBBCh MBA
Senior Director – Commercial Activities & Strategic Planning
Adam Love has experience in clinical development, medical affairs and business development from various roles within the pharmaceutical industry. Previously, he has held the position of medical director at Cephalon and Archimedes Pharma; and as business development director at Norgine and Cephalon, where he worked on the acquisition of Zeneus Pharma. He gained his medical degree from the University of the Witwatersrand, South Africa and his MBA with distinction from the University of Durham.
|
